click below
click below
Normal Size Small Size show me how
PT6,Unit2
| Question | Answer |
|---|---|
| ESTRADIOL CYPIONATE/MEDROXYPROGESTERONE ACETATE INJECTION | LUNELLE |
| LEVONORGESTREL SUBDERMAL IMPLANT MEDROXYPROGESTERONE INJECTION | NORPLANT DEPO-PROVERA |
| NORETHINDRONE TABLETSNORGESTREL TABLETS | ORTHO-MICRONOROVRETTE |
| LEVONORGESTREL TABLETSLEVONORGESTREL/ETHYNYL ESTRADIOL | PLAN BPREVEN |
| ESTROGEN AND PROGESTIN(VARYING STRENGTHS OF EACH) | ALESSE, LEVLEN, LO/OVRAL, NORDETTE, ORTHOCYCEN, ORTHO-NOVUM 7/7/7, ORTHOTRI-CYCLEN LO, SEASONALE, TRIPHASIL-28, TRIVORA, YASMIN |
| ETONOGESTREL 120 MCG AND ETHINYLESTRADIOL 15 MCG VAGINAL RING | NUVARING |
| NORELGESTROMIN 150 MCGAND ETHINYL ESTRADIOL 20 TRANSDERMAL PATCH | ORTHO EVRA PATCH |
| ESTRADIOL | ESTRACE |
| ESTRADIOL TRANSDERMAL SYSTEM | ESTRADERMCLIMARA,VIVELLE-DOT |
| ESTRADIOL CYPIONATE | DEPO-ESTRADIOL |
| ESTRADIOL VALERATE | DELESTROGEN |
| CONJUGATED ESTROGENS | PREMARIN |
| ESTROPIPATE | OGEN |
| DIENESTROL | ORTHO DIENESTROL |
| ETHINYL ESTRADIOL | ESTINYL |
| DIETHYLSTILBESTROL (DES) | DIETHYLSTILBESTROL |
| COMBINED ESTROGEN-PROGESTIN | PREMPRO,PREMPHASE,COMBIPATCH |
| RALOXIFENE | EVISTA |
| PROGESTERONE | PROGESTERONE |
| MEGESTROL ACETATE | MEGACE |
| MEDROXYPROGESTERONE | PROVERA,DEPO-PROVERA |
| OXYMETHOLONE | ANADROL-50 |
| STANOZOLOL | WINSTROL |
| OXANDROLONE | OXANDRIN |
| NANDROLONEPHENPROPIONATE | DURABOLINHYBOLIN IMPROVED |
| NANDROLONE DECANOATE | DECA-DURABOLIN,NEO-DURABOLIC,HYBOLIN DECANOATE-50,HYBOLIN DECANOATE-100,ANDROLONE-D 200 |
| ALPROSTADIL | MUSE URETHRAL PELLET,CAVERJECT,EDEX |
| SILDENAFIL | VIAGRA |
| PROPIONATE IN OIL | TESTOSTERONE PROPIONATE |
| ENANTHATE IN OIL | DELATESTRYL |
| CYPIONATE IN OIL | DEPO-TESTOSTERONE |
| AQUEOUS INJECTION | TESTOSTERONE AQUEOUS |
| TESTOSTERONE TRANSDERMALSYSTEM (CIII) | TESTODERMANDRODERM |
| METHYLTESTOSTERONE (CIII) | ORETON METHYLANDROID |
| FLUOXYMESTERONE (CIII) | HALOTESTIN |
| DANAZOL | DANOCRINE |
| FLUTAMIDE | EULEXIN |
| FINASTERIDE | PROSCARPROPECIA - HAIR GROWTH |
| TESTOSTERONE/ESTRADIOL | DEPO-TESTADIOL |
| ESTROGENS/METHYLTESTOSTERONE | ESTRATEST |
| ESTOGENS/METHYLTESTOSTERONE | ESTRATEST HS |
| LEUPROLIDE ACETATE | LUPRONLUPRON DEPOT |
| GOSERELIN ACETATE | ZOLADEX |
| NORETHINDRONE ACETATE | AYGESTIN |
| LEVONORGESTREL | NORPLANT SYSTEM |
| MONOPHASIC - ORTHO-NOVUM 1/35, 1/50 | FIXED DOSES OF ESTROGEN/PROGESTIN FOR 21 DAYS,OLDEST FORM |
| BIPHASIC - ORTHO-NOVUM 10/11 | FIXED STROGEN/INCREASED PROGESTIN FOR LAST 11 DAYS |
| TRIPHASIC - ORTHO-NOVUM 7/7/7 | DOSE OF PROGESTIN INCREASE EVERY 7 DAYS W/FIXED OR INCREASE OF ESTROGEN |
| MONOPHASIC, BIPHASIC, TRIPHASIC | TRYING TO MIMIC THE PERIOD CYCLE |
| PROGESTERONE(DELIVERS PROGESTERONE 65MCG/DAY OVER 1 YEAR) | PROGESTASERT |
| NORETHINDRONE | MICRONOR |
| NORGESTREL | OVRETTE |
| CLOMIPHENE | CLOMID |
| UROFOLLITROPIN | METRODIN, FERTINEX |
| MENOTROPINS | PERGONALHUMEGONREPRONEXFOLLISTIM |
| TAMOXIFEN | NOLVADEX |
| ANASTROZOLE | ARIMIDEX |
| THE MOSTE FERTILE TIME DURING THE FEMALE REPRODUCTIVE CYCLE IS: | MIDCYCLE, USUALLY DAY 12-14 |
| THE MAIN FUNCTION OF ESTRADIOL IS | TO STIMULATE DEVELOPMENT OF THE UTERINE LINING AND THE MAMMARY GLANDS |
| THE MAIN FUNCTION OF PROGESTERONE IS | TO MAINTAIN THE UTERINE LINING IF IMPLANTATION OCCURS |
| AZOOSPERMIA IS A CONDITION CHARACTERIZED BY | NO SPERM PRODUCTION |
| WHAT OCCURS IN BPH | THE PROSTATE GLAND ENLARGES |
| BPH CAN BE TREATED WITH | ALPHA-ADRENERGIC BLOCKERS |
| THE MAIN RISK FACTOR FOR BPH IS | HTN |
| WHICH OF THE FOLLOWING IS A CONTRAINDICATION FOR WOMEN WHO ARE TAKING ORAL CONTRACEPTIVES | ALL OF THE ABOVE |
| WHICH OF THE FOLLOWING CONTRACEPTIVE AGENTS IS A SUBDERMAL IMPLANT | NORPLANT |
| WHICH OF THE FOLLOWING IS NOT A MECHANISM OF ACTION FOR ORAL CONTRACEPTIVES | PREVENT OVULATION |
| DYSMENORRHEA | PAINFUL MENSTRUATION, HEADACHE, CRAMPS, BLOATING, ANOREXIA, N/V. BEFORE PERIOD BEGINS THESE SYMPTOMS ARE CALLED PMS OR PREMENSTRUAL SYNDROME |
| AMENORRHEA | ABSENCE OF NORMAL MENSTRUATION. MAY BE DUE TO TUMOR, PREGMANCY, HORMONE IMBALANCE OR MENOPAUSE |
| PID (PELVIC INFLAMMATORY DISEASE) | INFECTION OF UTERUS, FALLOPIAN TUBES OR OVARIES. CAN LEAD TO INFERTILITY, SEPTIC SHOCK AND DEATH |
| TOXIC SHOCK SYNDROME (TSS) | INFECTION USUALLY CAUSED BY STAPH BACTERIA. CAN SPREAD FROM REPRODUCTIVE ORGANS TO OTHER TISSUES. THOUGHT TO BE RELATED TO USE OF SUPER-ABSORBENT TAMPONS |
| VAGINITIS | INFLAMMATION OR INFECTION OF VAGINAL TISSUES, DUE TO STD'S, YEAST OR BACTERIAL INFECTION |
| ENDOMETRIOSIS | DISPLACED ENDOMETRIAL LINING OUTSIDE UTERUS, ESPECIALLY ON PELVIC AND ABDOMINAL ORGANS. CAN BE SITE OF ECTOPIC PREGNANCY |
| MENOPAUSE | PHASE OF WOMAN'S LIFE WHEN MENSTRUATION CEASES, USUALLY BEGINNING AROUND AGE 50. SYMPTOMS DUE TO DECREASE IN HORMONAL LEVELS |
| OOPHORECTOMY | SURGICAL REMOVAL OF ONE OR BOTH OVARIES |
| HYSTERECTOMY | SURGICAL REMOVAL OF UTERUS |
| OOPHORSALPINGECTOMY | SURGICAL REMOVAL OF OVARIES AND FALLOPIAN TUBES |
| ORCHIDECTOMY | SURGICAL REMOVAL OF TESTES |